RxDoctor Payments Data

Stephen Loehr

Vascular & Interventional Radiology · Cary, NCNPI 1871513234

Payments from drug & device makers

What this record shows

This record is dominated by other: $59,500 of the $71,833 with a category attached, or 82.8%. Angiodynamics, Inc. accounts for 98.6% of it on its own, with 16 other manufacturers making up the rest. Among vascular & interventional radiology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$71,833in general payments, 2019–2025

Across 82 payments — averaging $876.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Angiodynamics, Inc.$71K
  • Boston Scientific$310
  • Bard Peripheral Vascular, Inc.$135
  • Guerbet LLC$121
  • Medtronic$107
  • Cook Medical LLC$77
  • plus $279 from 11 others

What the payments were for

  • Food & beverage$1,5422%
  • Education$10,79215%
  • Other$59,50083%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$71,833 in reported general payments places this provider in the 95th percentile of 106 vascular & interventional radiology providers in North Carolina.

See all vascular & interventional radiology providers in North Carolina

Medicare billing

Part B allowed, 2024
$1,130,732
Medicare patients
369
Services billed
19,159

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate14$220

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Cary

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →